Addressing the need for tick-borne disease care where the problem starts… with the tick!
With over 475,000 new cases per year, Lyme disease is only the starting point for understanding the risk of a tick bite
TickReport delivers faster, more confident decisions for tickborne disease by combining gold-standard laboratory testing with clear, actionable reporting—so that those bitten can make evidence-based decisions.
What TickReport offers
Comprehensive, validated testing: PCR and serology for the full spectrum of clinically relevant tickborne pathogens, plus co-infection panels. Tests are performed using technologies developed at the University of Massachusetts in a laboratory using validated methods and up-to-date pathogen panels.
Rapid turnaround: Streamlined workflows and prioritized processing shorten time-to-result so clinicians can start or adjust therapy sooner when it matters most.
High specificity and sensitivity: Rigorous assay design and quality controls reduce false positives and negatives, improving diagnostic confidence and avoiding unnecessary treatments or missed infections.
Co-infection detection: Simultaneous testing for common co-pathogens uncovers mixed infections that can alter presentation and treatment, preventing incomplete therapy and prolonged symptoms.
Why clinicians and health systems recommend TickReport
Trusted lab quality and rigorous validation for reliable results
Clinically oriented reports that integrate interpretation and next steps
Co-infection panels and comprehensive pathogen coverage
Responsive turnaround and laboratory support to streamline care pathways
TickReport turns complex tick testing into a clear, reliable risk assessment tool—helping patients make decisions and giving clinicians ability to diagnose with confidence, treat more precisely, and improve patient outcomes while controlling costs.
Changing the surveillance paradigm
Measuring the risk of Zoonoses requires novel approaches to surveillance: approaches that center on the humans affected most by vector-borne diseases. The core of this work since 2006 has been the TickReport testing service, which offers qPCR pathogen testing to the public. Individuals can use these results to gauge their risk of pathogen exposure from a tick bite, but the anonymized data from that tick also goes into our nationwide tick surveillance database.
Real results
Science isn’t just a product, it’s a process of accumulating information (data) under exacting standards. Unlike private diagnostic companies or even many health agencies, we make the data we’re gathering freely available to the public. And when we occasionally write reports on our findings, we put these reports through the rigors of peer review to ensure that what you read is not just our opinion, but represents the best understanding rooted in evidence.
